- Home
- PEV vs INDP Comparison
PEV vs INDP Comparison
Compare PEV & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEV
- INDP
- Stock Information
- Founded
- PEV 2002
- INDP 2000
- Country
- PEV United States
- INDP United States
- Employees
- PEV N/A
- INDP N/A
- Industry
- PEV Auto Manufacturing
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- PEV Consumer Discretionary
- INDP Health Care
- Exchange
- PEV Nasdaq
- INDP Nasdaq
- Market Cap
- PEV 15.4M
- INDP 10.2M
- IPO Year
- PEV 2022
- INDP N/A
- Fundamental
- Price
- PEV $0.30
- INDP $0.87
- Analyst Decision
- PEV
- INDP Strong Buy
- Analyst Count
- PEV 0
- INDP 2
- Target Price
- PEV N/A
- INDP $8.50
- AVG Volume (30 Days)
- PEV 974.9K
- INDP 22.1K
- Earning Date
- PEV 01-07-2025
- INDP 11-12-2024
- Dividend Yield
- PEV N/A
- INDP N/A
- EPS Growth
- PEV N/A
- INDP N/A
- EPS
- PEV N/A
- INDP N/A
- Revenue
- PEV $21,635,000.00
- INDP N/A
- Revenue This Year
- PEV N/A
- INDP N/A
- Revenue Next Year
- PEV N/A
- INDP N/A
- P/E Ratio
- PEV N/A
- INDP N/A
- Revenue Growth
- PEV 324.30
- INDP N/A
- 52 Week Low
- PEV $0.27
- INDP $0.81
- 52 Week High
- PEV $1.60
- INDP $3.10
- Technical
- Relative Strength Index (RSI)
- PEV 38.32
- INDP 33.67
- Support Level
- PEV $0.29
- INDP $0.81
- Resistance Level
- PEV $0.30
- INDP $1.01
- Average True Range (ATR)
- PEV 0.03
- INDP 0.06
- MACD
- PEV 0.00
- INDP -0.00
- Stochastic Oscillator
- PEV 5.56
- INDP 11.77
About PEV Phoenix Motor Inc.
Phoenix Motor Inc is an electrification solutions provider for the commercial vehicle industry as well as other industries. It designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium-duty electric vehicles (EVs) and markets and sells electric vehicle chargers for the commercial and residential markets. The company operates two primary brands, Phoenix Motorcars, which focuses on commercial products including medium-duty electric vehicles, chargers, and electric forklifts, and EdisonFuture which intends to offer light-duty electric vehicles.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.